Traws Pharma (TRAW) Current Assets (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Current Assets of $5.7 million for Q1 2026, down 69.96% year-over-year from $18.9 million in Q1 2025, and down 29.0% quarter-over-quarter from $8.0 million in Q4 2025.
Traws Pharma (TRAW) Current Assets (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Current Assets for 15 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 69.96% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (down 69.96% YoY), while the FY2025 annual figure was $8.0 million, down 68.02% from the prior year.
- Current Assets retreated to $5.7 million in Q1 2026 per TRAW's latest filing, from $8.0 million in the prior quarter.
- Across five years, Current Assets topped out at $51.4 million in Q1 2022 and bottomed at $5.7 million in Q1 2026.
- Historically, Current Assets has averaged $25.1 million across 5 years, with a median of $22.7 million in 2023.
- Annual changes were most pronounced in 2024 — Current Assets advanced 10.11% — and 2026, when it plunged 69.96%.
- Traws Pharma's Current Assets stood at $39.3 million in 2022, then sank by 42.41% to $22.7 million in 2023, then increased by 10.11% to $25.0 million in 2024, then plunged by 68.02% to $8.0 million in 2025, then retreated by 29.0% to $5.7 million in 2026.
- Business Quant data shows TRAW's Current Assets at $5.7 million in Q1 2026, $8.0 million in Q4 2025, and $9.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 1.76 Bn |
| 10 | Traws Pharma | 5.54 Mn | 519,253.28 | - | 9.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.67 Mn |
| Dec 31, 2025 | 7.98 Mn |
| Sep 30, 2025 | 9.63 Mn |
| Jun 30, 2025 | 15.37 Mn |
| Mar 31, 2025 | 18.86 Mn |
| Dec 31, 2024 | 24.95 Mn |
| Sep 30, 2024 | 8.92 Mn |
| Jun 30, 2024 | 18.67 Mn |
| Mar 31, 2024 | 18.15 Mn |
| Dec 31, 2023 | 22.66 Mn |
| Sep 30, 2023 | 27.01 Mn |
| Jun 30, 2023 | 30.45 Mn |
| Mar 31, 2023 | 35.04 Mn |
| Dec 31, 2022 | 39.35 Mn |
| Sep 30, 2022 | 43.75 Mn |
| Jun 30, 2022 | 48.03 Mn |
| Mar 31, 2022 | 51.38 Mn |
| Dec 31, 2021 | 55.43 Mn |
| Sep 30, 2021 | 59.94 Mn |
| Jun 30, 2021 | 44.19 Mn |